title: The renewed potential for folate antagonists in contemporary cancer chemotherapy.
authors.affiliation: Parke-Davis Pharmaceutical Research Division, Ann Arbor, Michigan 48105.
authors.forename: E M
authors.initials: EM
authors.lastname: Berman
authors.forename: L M
authors.initials: LM
authors.lastname: Werbel
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005492:Folic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D011799:Quinazolines / Q000627:therapeutic use*; D013329:Structure-Activity Relationship; D013940:Thymidylate Synthase / Q000037:antagonists & inhibitors*
chemical_list: D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists; D011799:Quinazolines; C031662:CB 3717; D005492:Folic Acid; D013940:Thymidylate Synthase